This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 115/17/2271    most recent CIRCULATIONAHA.106.628859v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, F. Articles by O’Connor, D. T. Search for Related Content PubMed PubMed Citation Articles by Rao, F. Articles by O’Connor, D. T. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Clinical genetics Hypertension - basic studies Clinical Studies

(Circulation. 2007;115:2271-2281.)
© 2007 American Heart Association, Inc.

Genetics

Catecholamine Release–Inhibitory Peptide Catestatin (Chromogranin A_352–372)

Naturally Occurring Amino Acid Variant Gly364Ser Causes Profound Changes in Human Autonomic Activity and Alters Risk for Hypertension

Fangwen Rao, MD; Gen Wen, MD, PhD; Jiaur R. Gayen, PhD; Madhusudan Das, PhD; Sucheta M. Vaingankar, PhD; Brinda K. Rana, PhD; Manjula Mahata, PhD; Brian P. Kennedy, PhD; Rany M. Salem, MPH; Mats Stridsberg, PhD; Kenneth Abel, PhD; Douglas W. Smith, PhD; Eleazar Eskin, PhD; Nicholas J. Schork, PhD; Bruce A. Hamilton, PhD; Michael G. Ziegler, MD; Sushil K. Mahata, PhD; Daniel T. O’Connor, MD

From the Departments of Medicine (F.R., G.W., J.R.G., M.D., S.M.V., M.M., B.P.K., R.M.S., K.A., B.A.H., M.G.Z., S.K.M., D.T.O.), Psychiatry (B.K.R., N.J.S.), Computer Science (E.E.), Pharmacology (D.T.O.), and Biology (D.W.S.), Polymorphism Research Laboratory (B.K.R., N.J.S.), and Center for Human Genetics and Genomics (N.J.S., D.T.O.), University of California at San Diego; the VA San Diego Healthcare System (S.K.M., D.T.O.), San Diego, Calif; and the Department of Medical Sciences (M.S.), University of Uppsala, Uppsala, Sweden.

Correspondence to Daniel T. O’Connor, MD, or Sushil K. Mahata, PhD, Department of Medicine and Center for Human Genetics and Genomics (0838), UCSD School of Medicine and VASDHS, 9500 Gilman Drive, La Jolla, CA 92093–0838. E-mail doconnor{at}ucsd.edu or smahata@ucsd.edu

Received March 31, 2006; accepted November 13, 2006.

Background— Chromogranin A, coreleased with catecholamines by exocytosis, is cleaved to the catecholamine release–inhibitory fragment catestatin. We identified a natural nonsynonymous variant of catestatin, Gly364Ser, that alters human autonomic function and blood pressure.

Methods and Results— Gly364Ser heterozygotes and controls underwent physiological and biochemical phenotyping, including catecholamine production, chromogranin A precursor, and its catestatin product. Case-control studies replicated effects of the gene on blood pressure in the population. Gly364Ser displayed diminished inhibition of catecholamine secretion from cultured neurons. Gly/Ser heterozygotes displayed increased baroreceptor slope during upward deflections (by 47%) and downward deflections (by 44%), increased cardiac parasympathetic index (by 2.4-fold), and decreased cardiac sympathetic index (by 26%). Renal norepinephrine excretion was diminished by 26% and epinephrine excretion by 34% in Gly/Ser heterozygotes. The coalescent dated emergence of the variant to 70 000 years ago. Gly364Ser was in linkage disequilibrium with 1 major Chromogranin A promoter haplotype, although promoter haplotypes did not predict autonomic phenotypes. The 364Ser variant was associated with lower diastolic blood pressure in 2 independent/confirmatory groups of patients with hypertension; genotype groups differed by 5 to 6 mm Hg, and the polymorphism accounted for 1.8% of population diastolic blood pressure variance, although a significant gene-by-sex interaction existed, with an enhanced effect in men.

Conclusions— The catestatin Gly364Ser variant causes profound changes in human autonomic activity, both parasympathetic and sympathetic, and seems to reduce risk of developing hypertension, especially in men. A model for catestatin action in the baroreceptor center of the nucleus of the tractus solitarius accounts for these actions.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				B. K. Rana, J. Wessel, V. Mahboubi, F. Rao, J. Haeller, J. R. Gayen, E. Eskin, A. M. Valle, M. Das, S. K. Mahata, et al. Natural Variation within the Neuronal Nicotinic Acetylcholine Receptor Cluster on Human Chromosome 15q24: Influence on Heritable Autonomic Traits in Twin Pairs J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 419 - 428. [Abstract] [Full Text] [PDF]

				J. R. Gayen, Y. Gu, D. T. O'Connor, and S. K. Mahata Global Disturbances in Autonomic Function Yield Cardiovascular Instability and Hypertension in the Chromogranin A Null Mouse Endocrinology, November 1, 2009; 150(11): 5027 - 5035. [Abstract] [Full Text] [PDF]

				L. Wang, F. Rao, K. Zhang, M. Mahata, J. L. Rodriguez-Flores, M. M. Fung, J. Waalen, M. G. Cockburn, B. A. Hamilton, S. K. Mahata, et al. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J. Am. Coll. Cardiol., September 1, 2009; 54(10): 944 - 954. [Abstract] [Full Text] [PDF]

				K. B. Helle The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions Cardiovasc Res, August 18, 2009; (2009) cvp266v2. [Abstract] [Full Text] [PDF]

				N. Biswas, J. L. Rodriguez-Flores, M. Courel, J. R. Gayen, S. M. Vaingankar, M. Mahata, J. W. Torpey, L. Taupenot, D. T. O'Connor, and S. K. Mahata Cathepsin L Colocalizes with Chromogranin A in Chromaffin Vesicles to Generate Active Peptides Endocrinology, August 1, 2009; 150(8): 3547 - 3557. [Abstract] [Full Text] [PDF]

				G. Di Comite, C. M. Rossi, A. Marinosci, K. Lolmede, E. Baldissera, P. Aiello, R. B. Mueller, M. Herrmann, R. E. Voll, P. Rovere-Querini, et al. Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-{alpha}-elicited endothelial activation J. Leukoc. Biol., January 1, 2009; 85(1): 81 - 87. [Abstract] [Full Text] [PDF]

				N. R. Mahapatra Catestatin is a novel endogenous peptide that regulates cardiac function and blood pressure Cardiovasc Res, December 1, 2008; 80(3): 330 - 338. [Abstract] [Full Text] [PDF]

				S. V. Kabadi and A. Ally Negative Cardiotropism by Catestatin and Its Variants Endocrinology, October 1, 2008; 149(10): 4778 - 4779. [Full Text] [PDF]

				T. Angelone, A. M. Quintieri, B. K. Brar, P. T. Limchaiyawat, B. Tota, S. K. Mahata, and M. C. Cerra The Antihypertensive Chromogranin A Peptide Catestatin Acts as a Novel Endocrine/Paracrine Modulator of Cardiac Inotropism and Lusitropism Endocrinology, October 1, 2008; 149(10): 4780 - 4793. [Abstract] [Full Text] [PDF]

				P.-a. B. Shih and D. T. O'Connor Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity Hypertension, June 1, 2008; 51(6): 1456 - 1464. [Full Text] [PDF]

				R. M. Salem, P. E. Cadman, Y. Chen, F. Rao, G. Wen, B. A. Hamilton, B. K. Rana, D. W. Smith, M. Stridsberg, H. J. Ward, et al. Chromogranin A Polymorphisms Are Associated With Hypertensive Renal Disease J. Am. Soc. Nephrol., March 1, 2008; 19(3): 600 - 614. [Abstract] [Full Text] [PDF]

				N. Biswas, S. M. Vaingankar, M. Mahata, M. Das, J. R. Gayen, L. Taupenot, J. W. Torpey, D. T. O'Connor, and S. K. Mahata Proteolytic Cleavage of Human Chromogranin A Containing Naturally Occurring Catestatin Variants: Differential Processing at Catestatin Region by Plasmin Endocrinology, February 1, 2008; 149(2): 749 - 757. [Abstract] [Full Text] [PDF]

				D. S. Goldstein Genotype and Vascular Phenotype Linked by Catecholamine Systems Circulation, January 29, 2008; 117(4): 458 - 461. [Full Text] [PDF]